Spots Global Cancer Trial Database for Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib
Official Title: COLONG: Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib
Study ID: NCT03386825
Conditions
Interventions
Study Description
Brief Summary: The aim of this local NIS(Non-Interventional Study) is to determine the proportion of Belgian patients with a duration of treatment(DoT) to Stivarga of 4 months or more in relation to the total population of Belgian metastatic colorectal cancer(mCRC) patients who were treated with Stivarga between the 1st of July 2015 and 31 July 2017. In addition, this study aims to describe the clinical characteristics of Belgian patients with a short- or long-term DoT to Stivarga.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Belgium, Multiple Locations, , Belgium
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
